|
List of Jounal Titles
A to Z index of Journal Title. Choose a letter.
Internal Medicine
83
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Pathogenetic mechanisms of autoimmune diseases. Distiny introducing pathogenesis and swinging.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Exophthalmic goiter and Hashimoto' disease.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Atrophic gastritis and malignant anemia.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Juvenile pathogenetic diabetes mellitus.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Goodpasture's syndrome.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Autoimmune hepatitis and primary biliary liver cirrhosis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Myasthenia gravis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ specific autoimmune diseases important for physicians. Multiple sclerosis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ nonspecific autoimmune diseases. Systemic lupus erythematosus.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ nonspecific autoimmune diseases. Chronic articular rheumatism.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ nonspecific autoimmune diseases. Multiple myositis and dermatomyositis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ nonspecific autoimmune diseases. Scaleroderma.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ nonspecific autoimmune diseases. Vasculitis syndrome.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Organ nonspecific autoimmune diseases. Sjoegren's syndrome.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Lupus nephritis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Central neuron lupus.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Anti-phospholipid antibody syndrome.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Thrombotic thrombopenic purpura.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Pulmonary hypertension.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Interstitial pneumonia.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Noteworthy intractable disease state of the collagen disease and the treatment. Femoral necrosis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Recent topics surrounding autoimmune diseases. Autoimmune diseases and apoptosis.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Recent topics surrounding autoimmune diseases. Virus and autoimmune diseases.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Recent topics surrounding autoimmune diseases. Target of Sjoegren's syndrome. .ALPHA. - Fodrin.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Recent topics surrounding autoimmune diseases. Targets of pemphigus. Desmoglein.
- The Latest information of medical care of autoimmune diseases. From organ specific diseases to collagen disease. Recent topics surrounding autoimmune diseases. Treatment for systemic lupus erythematosus by accessory stimulation block.
- Illustrated cases. Primary sclerosing cholangitis.
- Gastroenterology at bedside 4. Anorexia, retching and vomiting. Their causes, and test for their diagnosis and therapy.
- Pros & Cons in internal medical care. Does myelitis based on atopy exist ?
- Comparison of hereditary and non-hereditary risk factors of cerebral venous thrombosis.
- QT extension and child sudden death syndrome.
- Trends of the world on drug tolerance of Mycobacterium tuberculosis.
- A Case of Spontaneous Regnession of Large Hepatocellular Carcinoma.
- A Case of Synchronous Hodgkin's Disease, Gastric Cancer and Bladder Cancer.
- A Case of Mid-ventricular Obstruction with Apical Aneurysm.
- A Case of ANCA-associated Vasculitis with Auricular Chondritis.
- A Case of Neuro-Behcet Syndrome with Onset of Sweet's Syndrome.
- A Case of Pachydermoperiostosis with Myelofibrosis and Pancytopenia.
- A Case of Isolated ACTH Deficiency with Destructive Thyrotoxicosis.
- An Elderly Case of Hyperthyroidism with Severe Derilium.
- Basedow's Disease Resistant to Oral Thiamazole Caused by Malabsorption of Thiamazole. A Case Report.
2
- Controversy of internal medical care. Respiratory organs. Significance of chemotherapy in treatment for non-small cell lung cancer.
- Controversy of internal medical care. Respiratory organs. Effectiveness of mass screening for lung cancer.
- Controversy of internal medical care. Respiratory organs. Classification of interstitial pneumonia. Idiopathic interstitial pneumonia.
- Controversy of internal medical care. Respiratory organs. Etiology of sarcoidosis and treatment plans.
- Controversy of internal medical care. Circulatory organs. Can myocardial infarction crisis be predicted by coronary arteriography ?
- Controversy of internal medical care. circulatory organs. Treatment selection for coronary artery multibranch lesions. Coronary intervention or bypass operation ?
- Controversy of internal medical care. Circulatory organs. Operative method selection for coronary artery operation. Thoracotomy coronary artery bypass surgery or MIDCAB ?
- Controversy of internal medical care. Circulatory organs. Normal values of home blood pressure.
- Controversy of internal medical care. Circulatory organs. Treatment selection for elderly breast aortic aneurysm.
- Controversy of internal medical care. Digestive tract. Appropriateness of preventive endoscopic treatment for esophageal and gastric varicose vein.
- Controversy of internal medical care. Digestive tract. Is elimination for Helicobacter pylori infectious disease without peptic ulcer necessary ?
- Controversy of internal medical care. Digestive tract. Are colon polyps forbidden to be leave ?
- Controversy of internal medical care. Digestive tract. Treatment for lung cancer. Internal-medical care or surgical care ?
- Controversy of internal medical care. Digestive tract. HCV high virus quantity. Should be treated or not ?
- Controversy of internal medical care. Digestive tract. Is HGV hepatitis virus or not ?
- Controversy of internal medical care. Digestive system. Is TTV hepatitis virus or not ?
- Controversy of internal medical care. Digestive system. Is pancreatic carcinoma cured by operation ?
- Controversy of internal medical care. The kidney. Ideal way of treatment for IgA nephropathy.
- Controversy of internal medical care. The kidney. ANCA and related nephritis.
- Controversy of internal medical care. The kidney. What are progressive mechanisms for chronic renal insufficiency ?
- Controversy of internal medical care. Blood. Evaluation of MRD in acute leukemia. How are results of RT - polymerase chain reaction utilized to the medical care ?
- Controversy of internal medical care. Blood. Indication of granulocytic colony stimulation factors for acute myelocytic leukemia.
- Controversy of internal medical care. Blood. How should protective measures for infectious disease be done ?
- Controversy of internal medical care. Nerves and muscles. Treatment for acute cerebral infarction. Indication of platelet aggregation inhibitors and thrombolytic agents.
- Controversy of internal medical care. Nerves and muscles. Primary care of Parkinson's disease. Are L - Dopa pharmaceuticals first choice ?
- Controversy of internal medical care. Nerves and muscles. Disease state of hereditary neurodegenerative disease. Are the pathological mechanisms clarified by identification of gene abnormalities ?
- Controversy of internal medical care. Nerves and muscles. Alzheimer's disease. Is deposition of amyloid .BETA. protein cause or result ?
- Controversy of internal medical care. Water and electrolytes. Treatment for lactic acidosis. Is administration of sodium bicarbonate effective ?
- Controversy of internal medical care. Water and electrolytes. Diagnosis of SIADH.
- Controversy of internal medical care. Water and electrolytes. Evaluation of dehydration. Noteworthy body findings and necessary test. Controversy of internal medical care. Water and electrolytes. Evaluation of dehydration. Noteworthy body findings and necessary test.
- Controversy of internal medical care. Infectious diseases. Ideal way of treatment for O157 infection.
- Controversy of internal medical care. Infectious diseases. Relation between Helicobacter pylori and gastric cancer, gastric malignant lymphoma.
- Controversy of internal medical care. Infectious diseases. Glyco peptide group antimicrobial agents, VRE and MRSA.
- Controversy of internal medical care. Collagen disease and rheumatism. New treatment for chronic articular rheumatism. Positioning of anti-cytokine therapy.
- Controversy of internal medical care. Collagen disease and rheumatism. Treatment strategy for rheumatism. Pyramid or reverse pyramid ?
- Controversy of internal medical care. Collagen disease and rheumatism. Treatment for intractable lupus.
- Controversy of internal medical care. Incretion and metabolisms. New classification and diagnostic criteria for diabetes mellitus.
- Controversy of internal medical care. Incretion and metabolisms. Setting of purpose of hyperlipidemia treatment.
- Controversy of internal medical care. Incretion and metabolisms. Optimization of diagnosis and treatment for osteoporosis.
- Controversy of internal medical care. Incretion and metabolisms. Possibility of QOL improvement of old people by hormone substitution therapy.
- Gastroenterology at bedside 5. Heartburn and deglutition difficulty.
- Pros & Cons in internal medical care. Problems in penicillin therapy for neurosyphilis.
- EB viruses and cellular signal transmission routes in lymphoma of immunodeficient patients.
- Apolipoprotein B gene mutation. Is the screening useful ?
- Early treatment strategy for non-Q wave acute myocardial infarction. Invasive treatment plans or conservative treatment policy ?
- A Case of Acute Mediastinitis that Responded Rapidly to Treatment.
- Two Cases of Bickerstaff's Brainstem Encephalitis.
- A Case of Myelitis after Herpes Simplex Viral Meningitis.
- A Case of Vitamin B1/B12 Deficiency with Progressive Motor-sensory Disturbance after Diuretic Administration.
- A Case of Polycystic Ovary Syndrome with Improvement of Insulin Resistance after Weight Reduction.
- A Case of Primary Hyperparathyroidism Associated with Spino-Cerebellar Degeneration.
3
- Parkinson's disease Latest information on disease state elucidation and medical care. Recent advances in treatment for Parkinson's disease and future problems.
- Parkinson's disease Latest information on disease state elucidation and medical care. What is Parkinson's disease ? Disease concept and epidemiology of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. What is Parkinson's disease ? Pathology and pathophysiology of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Diagnosis of Parkinson's disease and marginal diseases. Procedures for diagnosis of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care.Diagnosis of Parkinson's disease and marginal diseases. Differential diagnosis of Parkinson's disease. Multiline atrophy.
- Parkinson's disease Latest information on disease state elucidation and medical care. Diagnosis of Parkinson's disease and marginal disease. Differential diagnosis of Parkinson's disease. Progressive supranuclear paralysis and cerebral cortex nucleus basalis degeneration disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Diagnosis of Parkinson's disease and marginal disease. Differential diagnosis of Parkinson's disease. Diffusive Lewy's corpuscle disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Diagnosis of Parkinson's disease and marginal disease. Differential diagnosis of Parkinson's disease. Sequential parkinsonism.
- Parkinson's disease Latest information on disease state elucidation and medical care. Diagnosis of Parkinson's disease and marginal disease. Image diagnosis. MRI of Parkinson's disease and marginal diseases.
- Parkinson's disease Latest information on disease state elucidation and medical care. Diagnosis of Parkinson's disease and marginal disease. Image diagnosis. PET and SPECT of Parkinson's disease and marginal diseases.
- Parkinson's disease Latest information on disease state elucidation and medical care. Forefront of Parkinson's disease and marginal diseasesf of marginal diseases' research. Exploration for causal gene of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Forefront of Parkinson's disease and marginal diseasesf of marginal diseases' research. Parkinson disease and oxidative stress.
- Parkinson's disease Latest information on disease state elucidation and medical care. Forefront of Parkinson's disease and marginal diseasesf of marginal diseases' research. Lewy's bodies and .ALPHA.-synuclein.
- Parkinson's disease Latest information on disease state elucidation and medical care. Forefront of Parkinson's disease and marginal diseasesf of marginal diseases' research. Parkinson's disease provocation material.
- Parkinson's disease Latest information on disease state elucidation and medical care. Pharmacotherapy of Parkinson's disease. Present state and problems of pharmacotherapy of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Pharmacotherapy of Parkinson's disease. Future prospect of pharmacotherapy of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Pharmacotherapy of Parkinson's disease. How to treat initial Parkinson's disease ?
- Parkinson's disease Latest information on disease state elucidation and medical care. Problems and countermeasures for treatment in longterm Parkinson's disease. Circadian variation, wearing-off and on-off of symptom.
- Parkinson's disease Latest information on disease state elucidation and medical care. Problems and countermeasures for long term Parkinson's disease. Dyskinesia and crouch foot phenomena.
- Parkinson's disease Latest information on disease state elucidation and medical care. Problems and countermeasures for long term Parkinson's disease. Dementia and neurologic manifestation.
- Parkinson's disease Latest information on disease state elucidation and medical care. Problems and countermeasures for long term Parkinson's disease.Autonomic neuropathic state and syndrome.
- Parkinson's disease Latest information on disease state elucidation and medical care. Problems and countermeasures for long term Parkinson's disease.Clinical significance of assay of blood level of L-Dopa.
- Parkinson's disease Latest information on disease state elucidation and medical care. New approach for treatment of Parkinson's disease. Gene therapy of Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. New approach for treatment of Parkinson's diseaseStereotaxic technique and stimulation therapy for Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. New approach for treatment of Parkinson's diseaseNew transplantation therapy for Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Life guidance and environmental factor of Parkinson's disease. Life guidance for Parkinson's disease.
- Parkinson's disease Latest information on disease state elucidation and medical care. Life guidance and environmental factor of Parkinson's disease. Parkinson's disease and environmental factor.
- Gastroenterology of bedside. 6. Abdominal distension and ascites.
- Drug information for avoidance of side effects. Clinical case of side effects to be warned. I. Endocrine drug. 1. Hepatic disorder by troglitazone.
- Should antiplatelet drug be administered for prevention of recurrence of lacunar infarction ?
- Treatment of localized stage perimalignat non-Hodgkin's lymphoma.
- New causal gene of chronic pancreatitis Mutation of cystic fibrosis gene.
- Recurrence rate of pregnancy and multiple sclerosis.
- A Case of Tuberculous Pleuro-peritonitis with Elevated CA125 Levels in Serum, Pleural Effusion and Ascites.
- An Effective Case of Endoscopic Laser Therapy for Gastric Antral Vascular Ectasia.
- Three Cases of Vitamin B1 Deficiency with Severe Polyneuropathy after Gastrectomy.
- A Case of Gasperini Syndrome with Masseter Disturbance Caused by Pontine Hemorrhage.
- A Case Report of Pituitary Metastasis of Colon Cancer.
- A Case of Wernicke's Encephalopathy with Serious Vomiting of Pregnancy.
- A Case of the Bleeding Meckel's Diverticulum Which was Showed by Technetium-99m labeled Red Blood Cell Scan and Angiography.
- A Case of Ataxic Sensory Neuropathy with Sicca Complex.
- Beneficial Effects of Prednisolone in a Case of Bone Marrow Necrosis with Unknown Cause.
- Thrombotic Thrombocytopenic Purpura Following Allogeneic Bone Marrow Transplantation for Chronic Myeloid Leukemia.
- A Case of Psoas Abscess Caused by Local Injection, Associated with Diabetic Mellitus.
- A Case of Painless Chronic Pancreatitis Resulted in Advanced Malnutrition Syndrome After Subtotal Gastrectomy During The Course of Diabetes Mellitus.
- A Case of Mitochondrial Diabetes Mellitus with Basal Ganglia Calcification, Diffuse Atrophy Involving Cerebrum, Cerebellum and Brain Stem and with Enlarged Fourth Ventricle.
4
- Forefront of medical care of osteoporosis. Aging society and medical care of the osteoporosis.
- Forefront of medical care of osteoporosis. Osteoporosis seminar. To understand disease state of the osteoporosis.
- Forefront of medical care of osteoporosis. Osteoporosis seminar. Osteoporosis from the viewpoint of Ca metabolism.
- Forefront of medical care of osteoporosis. Osteoporosis seminar. Starting period of treatment and long time of treatment.
- Forefront of medical care of osteoporosis. Osteoporosis seminar. Old people QOL and osteoporosis.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Is prevention of the osteoporosis possible ?
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Present of examination for osteoporosis and the problems.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Diagnostic criterion of the osteoporosis. Utilization in daily life.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Gist of differential diagnosis in daily medical care.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Practice of bone quantity measurement and reading test values. From diagnosis and evaluation of the therapeutic effect.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Plain roentgenogram and MRI diagnosis of spinal compression fractures by osteoporosis. Diagnostic problems by the plain roentgenogram and MRI classification.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Present of clinical application of bone metabolism markers and prospects.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Male's osteoporosis and the diagnostic criteria.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Information presented to patients. To get informed consent.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Guidelines of treatment and the utilization.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Effectiveness of diet therapy and points of guidance.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Theory and practice of exercise therapy.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Promotion of pharmacotherapy for "bone quantity decreased" patients.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Promotion of pharmacotherapy for 50 ages level patients.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Promotion of pharmacotherapy after 60 ages.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Treatment and prognosis for osteoporosis fractures.
- Forefront of medical care of osteoporosis. Advances of prevention and diagnosis. Promotion of the treatment from the viewpoint of Evidence - based medicine. Development and present of preventive orthosis for osteoporosis fractures.
- Forefront of medical care of osteoporosis. Systemic health care and medical care of osteoporosis. Ideal way special ambulatory treatment for osteoporosis and cooperation between hospital and clinics.
- Forefront of medical care of osteoporosis. Systemic health care and medical care of osteoporosis. Relation with other lifestyle habit diseases.
- Forefront of medical care of osteoporosis. Systemic health care and medical care of osteoporosis. Prevention of steroid osteoporosis and the treatment.
- Forefront of medical care of osteoporosis. Systemic health care and medical care of osteoporosis. Importance of falling down prevention and the countermeasures.
- Forefront of medical care of osteoporosis. Intranucleus receptors and the osteoporosis.
- Forefront of medical care of osteoporosis. Mechanisms of bone resorption and the control.
- Forefront of medical care of osteoporosis. Present of search of causal gene ( group ) and future possibility.
- Gastroenterology at bedside 7. Medical care of patients with complains of defecation abnormalities.
- Chemical information for prevention of side effects. Clinical cases with side effects. Endocrine drugs 2. Hepatic disorders by .ALPHA. - glucosidase inhibitory medicines.
- Is immunoglobulin massive dose therapy effective for treatment for multiple sclerosis ?
- A Case of Inflammatory Pesudotumor of the Lung Successfully Treated with Steroid Therapy.
- A Case of Biloma Accompanied with Bile Duct Stone after Cholecystomy.
- A Novel Mutation in the Vasopressin V2 Receptor Gene in Female with Congenital Nephrogenic Diabetes Insipidus.
- Low-Dose Simvastatin Induced Rhabdomyolysis Successfully Treated by Early Plasma-Exchange and Hemodialysis for Prevention of Renal Failure.
- Reactive Arthritis Induced by Yersinia enterocolitica. A Case Report.
- A Case of Graves' Disease Associated with Panic Disorder.
- Psychogenic Polydipsia after the Operation for Pituitary Apoplexy.
- A Case of Subacute Cerebellar Degeneration with Anti-Yo Antibody.
5
- Forefront of coronary intervention treatment. History of coronary intervention and background of appearing new device.
- Forefront of coronary intervention treatment.Knowledge for understanding coronary intervention.Pathological examination of coronary intervention for stable plaques and unstable plaques.
- Forefront of coronary intervention treatment. Knowledge for understanding coronary intervention. Mechanism of restenosis after coronary intervention.
- Forefront of coronary intervention treatment. Knowledge for understanding coronary intervention. What can be studied from results of large-scale test compared to PTCA and CABG ?
- Forefront of coronary intervention treatment. Knowledge for understanding coronary intervention. How should be used properly new device ?
- Forefront of coronary intervention treatment. Knowledge for understanding coronary intervention. Stent.
- Forefront of coronary intervention treatment. Present state and future of new device. Rotablator.
- Forefront of coronary intervention treatment. Present state and future of new device. DCA.
- Forefront of coronary intervention treatment. Present state and future of new device. Cutting balloon.
- Forefront of coronary intervention treatment. Present state and future of new device. Laser.
- Forefront of coronary intervention treatment. Present state and future of new device. TEC.
- Forefront of coronary intervention treatment. Treatment strategy for complicated lesion. PTCA for chronic complete imperforation.
- Forefront of coronary intervention treatment. Treatment strategy for complicated lesion. Inlet, bifurcation and left principal arterial lesion.
- Forefront of coronary intervention treatment. Treatment strategy for complicated lesion. Restenosis in stent.
- Forefront of coronary intervention treatment. Treatment strategy for complicated lesion. Multibranch lesion.
- Forefront of coronary intervention treatment. Countermeasures for restenosis after coronary intervention. Prevention of restenosis by pharmacotherapy.
- Forefront of coronary intervention treatment. Countermeasures for restenosis after coronary intervention. Intravenous irradiation.
- Forefront of coronary intervention treatment. Recent advances in therapeutic effect evaluation. Physiological evaluation of coronary circulation by flow wire and pressure wire.
- Forefront of coronary intervention treatment. Recent advancs in therapeutic effect evaluation. Vascular endoscope.
- Forefront of coronary intervention treatment. Recent advances in therapeutic effect evaluation. Intravenous echocardiography.
- Forefront of coronary intervention treatment. Recent topics on coronary intervention. Transradial coronary intervention.
- Forefront of coronary intervention treatment. Recent topics on coronary intervention. Local drug delivery.
- Forefront of coronary intervention treatment. Recent topics on coronary intervention. Combination therapy of MID-CAB and intervention.
- Forefront of coronary intervention treatment. Recent topics on coronary intervention. Percutaneous TMR.
- Forefront of coronary intervention treatment. Recent topics on coronary intervention. Angio Jet.
- Forefront of coronary intervention treatment. Recent topics on coronary intervention. Gene therapy.
- Gastroenterology in bedside. 8. Endoscopy of bedside.
- Drug information for avoiding side effects Clinical cases of side effect to be specifically noted. 1. Endocrine drug. 3. Rhabdomyolysis caused by HMG-CoA reductase inhibitor.
- What is the first choice therapy in chronic inflammation demyelinating multiple neuritis ?
- Treatment of retinoic acid less reactive acute promyelocytic leukemia caused by arsenous acid (As2O3).
- Effectiveness and problem of new antiviral drug lamivudine for chronic hepatitis B.
- A Case of Systemic Lupus Erythematosus Developed with Perforated Ulcer of the Small Intestine.
- A Case of Double Pylorus Manifesting as Hematemesis.
- A Case of Liver Injury Induced by Human Neutral Protamine Hagedorn Insulin Biosynthesized by Yeast.
- A Case of Polyarteritis Nodosa with Severe Coronary Artery Involvements.
- A Case of Tricuspid Valve Infective Endocarditis with HTLV-1 Carrier.
- Effective Cocoa Infusion Therapy for a Patient with Anemia and Neutropenia Caused by Copper Deficiency.
- A Case of Polycycthemia Vera with Liver Abscess.
- A Case of Autoimmune Hepatitis Associated with Hepatocellular Carcinoma.
6
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Bronchoscope.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Pneumoscope.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Cardiac catheter test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. PTCA.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Defibrillation.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Upper digestive tract endoscopic test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Lower digestive tract endoscopic test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Endoscopic demucosation and polypectomy.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Ultrasonic endoscopic test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Digestive system biopsy.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. PEIT and PMCT. Percutaneous local therapy for hepatoma.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. TAE.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. ERCP and EST/EPBD.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. PTC and PTCD.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Kidney biopsy.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Dialysis and hemocatharsis.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Central venous alimentation.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. HIV test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Neurophysiological test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Nervous and muscular biopsy.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Fluid test.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. PET and SPECT.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Bone marrow paracentesis and bone marrow biopsy.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Blood transfusion.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Hemopoietic stroma sampling and transplantation.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Gene diagnosis.
- Practice of informed consent. Points of explanations to patients I. Test and treatment technique edition. Prenatal diagnosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Bronchitis and pneumonia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Bronchial asthma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Chronic obstructive pulmonary diseases.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Interstitial pneumonia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Sarcoidosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Pulmonary thromboembolism.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Pulmonary hypertension.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Lung small cell carcinoma and lung non-small cell carcinoma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Mediastinal tumors.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Respiratory organs. Spontaneous pneumothorax.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Congestive heart failures.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Angina pectoris.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Myocardial infarction.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Cardiomyopathy.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Congenital heart diseases.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Acquired heart diseases.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Supraventricular and ventricular premature beat.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Atrial fibrillation and flutter.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Hypertension and hypotension.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Shock.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Aortic aneurysm and aortic dissociation.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Arteriosclerosis obliterans.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Circulatory organs. Aortitis syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Regurgitant esophagitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Esophageal cancer.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Gastric and duodenal ulcer, and chronic gastritis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Gastric cancer and gastric submucous tumors.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Ileus.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Colonic polyps, colonic cancer and rectal cancer.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Digestive tracts. Crohn's disease and ulcerative colitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Acute hepatitis and fulminant hepatitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Chronic hepatitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Liver cirrhosis, esophgeal and gastric varicosis and hepatoma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. The fatty liver.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Autoimmune hepatitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Primary biliary liver cirrhosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Idiopathic portal hypertension.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Cholelithiasis, cholecystitis and choledochal duct gallstones.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Biliary tract cancer and pancreatic carcinoma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Acute pancreatitis and chronic pancreatitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The liver, bile and pancreas. Pacreatic lithiasis and pancreatic cysts.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. IgA nephropathy.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Nephrotic syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Glomerulonephritis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Renal insufficiency.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Asymptomatic hematuria.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Proteinuria and erythrocyturia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Renal amyloidosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Hemolytic uremic syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Renal cell carcinoma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The kidney. Urinary calculi.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. Tuberculosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. Glandular fever.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. HIV infection and AIDS.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. Traveler's diarrhea.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. Meningitis and encephalitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. Septicemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. Food poisoning.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Infectious diseases. MRSA infection.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Chronic articular rheumatism.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Systemic lupus erythematosus.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Systemic scleroderma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Vasculitis syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Sjoegren's syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Behcet's disease.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Multiple myositis and dermatomyositis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Allergic rhinitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Allergy and rheumatism. Atopic dermatitis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Cerebral infarction and cerebral hemorrhage.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Alzheimer's disease.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Epilepsy.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Parkinson's disease.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Multiple sclerosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Prion disease.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Gui ll ain - Barre's syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Myasthenia gravis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. The nerves. Muscular dystrophy.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Hypochromic anemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Aplastic anemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Myelodysplastic syndrome.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Acute lymphatic leukemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Acute myelocytic leukemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Chronic myelocytic leukemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Primary polycythemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Non-Hodgkin's lymphoma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Hodgkin's disease.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Multiple myeloma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Blood. Idiopathic thrombocytopenic purpura.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Metabolism. Diabetes mellitus.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Metabolism. Hyperlipidemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Metabolism. Hyperuricemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Metabolism. Obesity.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Hyperthyroidism. Exophthalmic goiter.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Hypothyroidism.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Adrenal incidentaloma.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Pituitary tumors.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Hypopituitarism.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Hyperprolactinemia.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Osteoporosis.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Parathyroid gland hyperism.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Erection failures.
- Practice of informed consent. Points of explanations to patients II. Disease edition. Endocrine system. Amenorrhea.
1
84
- Chronic renal insufficiency. Is the progress stopped ? Approach on the progress of the chronic renal insufficiency.
- Chronic renal insufficiency. Is the progress stopped ? For understanding the chronic renal insufficiency. Disease state for chronic renal insufficiency and the control. What and how far is treated ?.
- Chronic renal insufficiency. Is the progress stopped ? For understanding the chronic renal insufficiency. Nutrition in the renal insufficiency and nutrition for not getting the ill.
- Chronic renal insufficiency. Is the progress stopped ? For understanding the chronic renal insufficiency. Practice of kidney functional test. How far is proved from urine and blood ?
- Chronic renal insufficiency. Is the progress stopped ? Mediators modifying the progress of the renal insufficiency. Renin - angiotensin system.
- Chronic renal insufficiency. Is the progress stopped ? Mediators modifying the progress of the renal insufficiency. TGF - .BETA..
- Chronic renal insufficiency. Is the progress stopped ? Mediators modifying the progress of the renal insufficiency. Insulin-like growth factors and somatotropin.
- Chronic renal insufficiency. Is the progress stopped ? Mediators modifying the progress of the renal insufficiency. Eicosanoid, active oxygen and mono nitrogen oxide.
- Chronic renal insufficiency. Is the progress stopped ? Mechanisms of the renal insufficiency progress from the viewpoint of tissue. Are differences in the renal insufficiency progress by types of nephritis ?
- Chronic renal insufficiency. Is the progress stopped ? Mechanisms of the renal insufficiency progress from the viewpoint of tissue. Role of glomerulus constitutive cells to glomerulosclerosis progress.
- Chronic renal insufficiency. Is the progress stopped ? Mechanisms of the renal insufficiency progress from the viewpoint of tissue. Significance of uriniferous tubule interstitial lesions.
- Chronic renal insufficiency. Is the progress stopped ? Renal insufficiency progress from the viewpoint of systemic diseases. Roles of hypertension.
- Chronic renal insufficiency. Is the progress stopped ? Renal insufficiency progress from the viewpoint of systemic diseases. Specific mechanisms to diabetes mellitus.
- Chronic renal insufficiency. Is the progress stopped ? Renal insufficiency progress from the viewpoint of systemic diseases. Should hyperlipidemia and hyperuricemia be treated ?
- Chronic renal insufficiency. Is the progress stopped ? Renal insufficiency progress from the viewpoint of systemic diseases. How does the cystic kidney progress ?
- Chronic renal insufficiency. Is the progress stopped ? Practice of treatment for renal insufficiency progress inhibiting. Is proteinuria really sick ?
- Chronic renal insufficiency. Is the progress stopped ? Practice of treatment for renal insufficiency progress inhibiting. Effectiveness of protein controlled diet.
- Chronic renal insufficiency. Is the progress stopped ? Practice of treatment for renal insufficiency progress inhibiting. Differences in ACE inhibitorsa and Ca antagonists.
- Chronic renal insufficiency. Is the progress stopped ? Practice of treatment for renal insufficiency progress inhibiting. Oral adsorbents. Advocacy of protein metabolite theory.
- Chronic renal insufficiency. Is the progress stopped ? Practice of treatment for renal insufficiency progress inhibiting. Merits and demerits of Erythropoietin.
- Chronic renal insufficiency. Is the progress stopped ? Control in the chronic renal insufficiency. Attention on pharmacotherapy.
- Chronic renal insufficiency. Is the progress stopped ? Control in the chronic renal insufficiency. Attention in the operation and fluid therapy for patients with renal insufficiency.
- Chronic renal insufficiency. Is the progress stopped ? Problems of dialytic therapy and the countermeasures. How far can dialytic therapy be waited ?
- Chronic renal insufficiency. Is the progress stopped ? Problems of dialytic therapy and the countermeasures. Disease state of dialysis osteopathia and the countermeasures.
- Chronic renal insufficiency. Is the progress stopped ? Problems of dialytic therapy and the countermeasures. Dialysis amyloidosis.
- Chronic renal insufficiency. Is the progress stopped ? Topics. Is gene polymorphism related to renal insufficiency progress ?
- Chronic renal insufficiency. Is the progress stopped ? Topics. Micro array assay. Large-scale retrieval of kidney disease related gene.
- Gastr o enter olo gy at bedside 9. Good application of tumor markers for medical examination on digestive tract diseases.
- Chemical information for side effect prevention. Noteworthy clinical cases II. Circulatory system drugs 1. Deterioration of myocardial infarction by Nifedipine fast releasing pharmaceuticals.
- Transition of mortality rate for coronary artery diseases and primary prevention, secondary prevention.
- Interferon ribavirin combination therapy for chronic hepatitis C.
- A Case of Protein-losing Enteropathy.
- A Case of Hepatic Failure Due to Budd-Chiari Syndrome Associated with Thrombosis of Inferior Vena Cava in a Patient Followed as Type C Hepatitis.
- A Case of Giant Angiomyolipoma Arising from the Renal Capsule.
- A Case of Benign Acute Myositis with Rhabdomyolysis due to Coxsackie Virus Type A9 Infection.
- A Patient of Kimura's Disease Observed for 17 Years.
- A Healthy Subject with Pseudo-elevation of CA19-9, CA125, SCC, TSH, FT4 and FT3 Caused by Human Anti-murine Antibodies(HAMA).
2
- The latest trends of viral hepatitis medical care. Development of hepatitis viral research.
- The latest trends of viral hepatitis medical care. Epidemiology and natural courses of viral hepatitis. Transition of acute hepatitis generating factors and the left problems.
- The latest trends of viral hepatitis medical care. Epidemiology and natural courses of viral hepatitis. Summing-up of hepatitis B viral mother and infant infection prevention.
- The latest trends of viral hepatitis medical care. Epidemiology and natural courses of viral hepatitis. Natural course of chronic hepatitis B.
- The latest trends of viral hepatitis medical care. Epidemiology and natural courses of viral hepatitis. Natural courses of chronic hepatitis C.
- The latest trends of viral hepatitis medical care. Advances of disease state elucidation for viral hepatitis. The latest knowledge of immunological mechanisms.
- The latest trends of viral hepatitis medical care. Advances of disease state elucidation for the viral hepatitis. Hepatitis viral infection and apoptosis.
- The latest trends of viral hepatitis medical care. Advances of disease state elucidation for the viral hepatitis. Hepatitis C virus and liver cancer generation.
- The latest trends of viral hepatitis medical care. Advances of diagnosis for the viral hepatitis. Approach to the diagnosis for the viral hepatitis.
- The latest trends of viral hepatitis medical care. Advances of diagnosis for the viral hepatitis. Hepatitis C virus determination and clinic of genotyping
- The latest trends of viral hepatitis medical care. Advances of diagnosis for the viral hepatitis. Usefulness of new Inuyama histological classification in the hepatitis medical care.
- The latest trends of viral hepatitis medical care. Advances of diagnosis for the viral hepatitis. Clinical significance of new viral HGV.
- The latest trends of viral hepatitis medical care. Advances of treatment for viral hepatitis B. Clinical significance of new viral TTV.
- The latest trends of viral hepatitis medical care. Advances of disease state elucidation of the viral hepatitis. Indication of interferon therapy for chronic hepatitis B from the viewpoint of long term prognosis.
- The latest trends of viral hepatitis medical care. Advances of treatment for viral hepatitis B. New antiviral agents, lamivudine.
- The latest trends of viral hepatitis medical care. Advances of treatment for viral hepatitis C. Clarified effect and limits of interferon.
- The latest trends of viral hepatitis medical care. Advances of treatment for viral hepatitis C. Liver carcinogenesis suppression effect of C type liver cirrhosis by interferon.
- The latest trends of viral hepatitis medical care. Advances of treatment for viral hepatitis C. Practice of anti-inflammatory therapy for interferon intractable cases and non-operation cases. Mainly on combination chemotherapy.
- The latest trends of viral hepatitis medical care. Advances of treatment for viral hepatitis C. Improvement on hepatitis C viral destruction rate through antiviral agents, rebavirin and interferon combination.
- The latest trends of viral hepatitis medical care. Viral hepatitis : Future prospects. Drug design based on crystal structure of virus proteins.
- The latest trends of viral hepatitis medical care. Viral hepatitis : Future prospects. Occurrence mechanisms of HBV drug resistance and new nuc l e o side ana lo gues.
- The latest trends of viral hepatitis medical care. Viral hepatitis : Future prospects. Hepatitis viral infection countermeasures with liver transplantation.
- The latest trends of viral hepatitis medical care. Viral hepatitis : Future prospects. Prospects of hepatitis C vaccine development.
- Gastr o enter olo gy at bedside 10. Diseases urgently needing surgical treatment and the timing.
- Drug information for side effect prevention. Mainly notable side effect cases. II. Circulatory system drugs. 2. Asthmatic attack by .BETA. blockers.
- How is Subc l inica l hyp o thyr o idism handled ?
- Clinical trial of etanercept for chronic articular rheumatism patients during Meth o trexate treatment.
- Cleavage enzymes for vWF in TTP/HUS patient blood plasma.
- A Case of Schoenlein-Henoch Purpura in Adult Responsive to Factor XIII Concentrate.
- Increased Antiacetylcholine Receptor Antibody Titer Associated with Cryptococcal Meningoencephalitis in a Patient with Liver Cirrhosis.
- A Case of Diabetes Insipidus Caused by Lymphocytic Infundibulo-hypophysitis.
- Hypoglycemia Induced by Disopyramide in a Case of Non-insulin Dependent Diabetes Mellitus Treated with Glibenclamide.
- A Case of Rapid Withdrawal of Glucocorticoid in a Kimura's Disease Treated with Suplatast Tosilate.
- A Case of Amyotrophic Lateral Sclerosis with Lance-Adams Syndrome.
- A Case of Myotonic Dystrophy with Pulmonary Infarction.
- Multicentric Castleman's Disease and Anaplastic Large Cell Lymphoma of the Skin in a Patient with AIDS.
3
- Advanced medical care of leukemia. Leukemia medical care without "incurable diseases". The past, present and futures.
- Advanced medical care of leukemia. How far would the leukemia be cured by hemopoietic stroma transplantation therapy ?
- Advanced medical care of leukemia. Problems relating to diagnosis and classification. Approach to patients. Points suspecting the leukemia and the treatment
- Advanced medical care of leukemia. Problems relating to the diagnosis and classification. Diagnostic criteria and disease type classification for leukemia.
- Advanced medical care of leukemia. Problems relating to the diagnosis and classification. Significance of French-American-British classification for the leukemia and the limits.
- Advanced medical care of leukemia. Problems relating to the diagnosis and classification. Chronic myelogenous leukemia and the nearby. French-American-British classification tentative plans.
- Advanced medical care of leukemia. Problems relating to the diagnosis and classification. Diagnosis for the chronic lymphatic leukemia and the classification.
- Advanced medical care of leukemia. For understading principles of the test and significance. Blood special staining test.
- Advanced medical care of leukemia. For understading principles of the test and significance. Chromosome analysis and FISH method.
- Advanced medical care of leukemia. For understading principles of test and significance. Diagnosis of minute persistent lesions using RT - PCR.
- Advanced medical care of leukemia. For understading principles of test and significance. Surface character test. Practice of flow cytometry techniques.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment concepts for acute leukemia. The historical transition.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment strategy of acute leukemia based on randomized comparison research.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment for acute myelocytic leukemia.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment for acute promyelocytic leukemia.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment for adult acute lymphatic leukemia.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Usage of G - CSF in treatment for the acute leukemia.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Chronic myelogenous leukemia. The latest data on IFN - .ALPHA. and bone marrow transplantation therapy.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment for the chronic lymphatic leukemia.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Treatment for the acute leukemia with pregnancy.
- Advanced medical care of leukemia. Advanced treatment for the leukemia. Prevention and treatment for acute leukemia central neuron invasion.
- Advanced medical care of leukemia. Present of hemopoietic stroma transplantation therapy. Practice of hemopoietic stroma transplantation therapy. What is doing in sterile rooms ?
- Advanced medical care of leukemia. Present of hemopoietic stroma transplantation therapy. Indication of hemopoietic stroma transplantation therapy for the acute leukemia.
- Advanced medical care of leukemia. Present of hemopoietic stroma transplantation therapy. Advances of hemopoietic cell transplantation between non-blood relations.
- Advanced medical care of leukemia. Recent topics on the leukemia. Present and futures of gene therapy for the leukemia.
- Advanced medical care of leukemia. Recent topics on the leukemia. Differential derived therapy for the acute promyelocytic leukemia. Retinoic acid and arsenic.
- Advanced medical care of leukemia. Recent topics on the leukemia. Telomere telomerase and the leukemia.
- Gastr o enter olo gy at bed-side 11. Operation results of upper and lower digestive tract diseases to memorize.
- Chemical information for side effect prevention. Clinical cases of noteworthy side effect III. Gastrointestinal drugs 1. Arrhythmia by Cisapride.
- Usefulness and safety of biguanite medicines.
- Suitability of treatment for hypertension.
- Gui ll ain - Barre's syndrome related to influenza vaccine inoculation.
- Relation between N o n u l cer dyspepsia and Helicobacter pylori.
- A Case of Kartagener's Syndrome with Atypical Mycobacteriosis.
- A Case of Pneumatosis Cystoides Intestinalis with a History of Frequent Recurrence.
- A Case of Colonic Muco-Submucosal Elongated Polyp of Cecum, Endoscopically Resected after Follow-up for 10 years.
- A Case of Peritoneal Serous Papillary Carcinoma Presented First Peritonitis Carcinomatosa Which Origin was Unknown.
- A Case of Giant Hemangioma of the Liver with Nephrotic Syndrome.
- A Case of Membranous Septal Aneurysm Diagnosed Using MRI.
- A Case of Painless Aortic Dissection Which was Discovered for Syncopal Attack, Dizziness and Fever.
- A Case of Relapsing Polychondritis in Elderly Woman.
- An Autopsy Case of Acute Lymphoblastic Leukemia with Extensive Dymyelinated Spinal Cord.
- A Case of Diabetes Millitus with Primary Hyperparathyroidism and Thyroid Papillary Carcinoma.
- Hyperglycemia and Autoimmune Hemolytic Anemia in a Patient with Acquired Immunodeficiency Syndrome(AIDS) Treated by Nerfinavir Containing Regimen.
4
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. What and how is changed by infectious disease new law : For physicians.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Pharyngitis, tonsillitis and acute upper respiratory tract inflammation.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Pneumonia and bronchitis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Hepatic-biliary system infectious diseases.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Digestive tract infectious diseases.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Septicemia and infectious endocarditis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Bacterial meningitis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Complex cystitis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis for bacterial infection and how to choose antimicrobial agents : Estimation of phlogogenic microbes and empiric therapy. Sexually infectious diseases.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Treatment for resistant infectious diseases. Treatment for Methici ll in resistance Staphylococcus aureus (MRSA).
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Treatment for resistant infectious diseases. Penicillin resistant Pneumococcus (PRSP) infectious diseases.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Treatment for resistant infectious diseases. Pseudomonas infectious diseases.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Treatment for resistant infectious diseases. Vancomycin resistant enterococcus (VRE) infectious diseases.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Treatment for resistant infectious diseases. Multiple drug resistant tuberculosis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for viral infectious diseases. Influenza.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for viral infectious diseases. Cytomegalovirus infection.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for viral infectious diseases. Viral hepatitis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for viral infectious disease. HIV infection.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for mycosis and protozoan infection and parasitic diseases. Deep mycosis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for mycosis and protozoan infection and parasitic diseases. Carinii pneumonia.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for mycosis and protozoan infection and parasitic diseases. Cryptosporidium disease and isospora disease.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Diagnosis and treatment for mycosis and protozoan infection and parasitic diseases. Taeniasis, nemathelminthiasis and trematodiasis.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Prevention of infection and risk management. Prevention of infection for compromised host.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Prevention of infection and risk management. Significance and indication of influenza vaccine and pneumococcus vaccine.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Prevention of infection and risk management. Correspondence to Mycobacterium tuberculosis germ excluding patients.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Prevention of infection and risk management. Countermeasures for Methici ll in resistant Staphylococcus aureus and g l yc opeptide resistant enterococcus infection.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Prevention of infection and risk management. Correspondence to pathogenic E. coli O 157 infectious persons.
- Practice of medical care of infectious diseases : Techniques of clinical judgement useful from today. Prevention of infection and risk management. Correspondence in needle accidents.
- End o crin olo gy at bed-side 1. Promotion of endocrine functional test. 1. Thyroid gland.
- Chemical information for side effect prevention. Clinical cases with noteworthy side effect. III. Gastrointestinal drugs. 2. Extrapyramidal tract symptoms by drugs with D2 - interception action.
- Suitability of thyroid hormone therapy for N o nthyr o ida l i ll ness syndr o me.
- Significance of cholesterol lowering therapy in coronary artery disease cases showing average cholesterol level.
- Atherosclerosis and carotid endosporium -tunica media hyperplasia.
- Detection of coronary artery advanced stenosis and obstruction by electron beam computed tomographic scanning.
- A Case of Portal Venous Gas Complicated with Adhesion Ileus.
- A Case of the Gallstone with Mercedes Benz Sign.
- Two Cases of Severe Alcoholic Hepatitis Successfully Treated with Hemocatharsis.
- A Case of Steroid-reactive Meningoencephalitis with Likely Diagnosis of Primary Angitis of the Central Nervous System.
- A Case of Subclavian Arterial Obstruction with Vertebral Arterial Anomaly.
- An Adult Case of Hypotonic Dehydration Probably Persisted for a Long Period.
5
- A Case of Nontraumatic Subcapsular Hematoma of the Kidney on an Anticoagulant Therapy.
- A Case of Central Nervous System Lupus with Transverse Myelopathy.
- Pancytopenia Developed 5 Years After the Diagnosis of Mixed Connective Tissue Disease.
6
- Effective Application of a Handy Pulse Oxymeter for the Diagnosis of Outpatient with Sleep Apnea Syndrome.
- A Successful Case of High Frequency Cather Ablation Therapy for Uncommon Type Atrial Flutter with Postoperated Fallot and Hetretotaxia.
- A Case of Measles Encephalitis in Youth.
- Sparfloxacin Allergy with Various Symptoms.
- A Case of Tuberculous Meningo-pleuritis with Intracranial Tuberculoma, which Appeared after Remission of Meningitis.
- A Case of Aconite Intoxication Accompanied by Mistake of Aconitum ("Torikabuto") Herbs for Anemone flaccida ("Nirinso").
- A Case of Chronic Myelomonocytic Leukemia with Acute Monocytosis and Appearing Isochromosome(17q).
1
| Copyright (c) 2006-2007 Japan Science and Technology Agency. All Rights Reserved. | |
